chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse concerning a male patient of unknown age. On an unknown date (reported as one unspecified patient received the vaccine about a year ago and the other unspecified patient received the vaccine about a couple of years ago), the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant therapy was reported. On an unknown date (reported as recently, the patient was diagnosed with shingles after receiving ZOSTAVAX. The patient sought an unspecified medical attention. An unspecified treatment was given to the patient. It was unspecified if any lab tests were performed. On an unknown date, the patient was recovered from shingles. The relatedness for shingles was unknown for ZOSTAVAX. This is one of the two reports from the same source. Additional information is not expected.
client complained of abdominal pain, headache and nausea after receiving 2nd dose of Moderna. Client had been sitting in observation when she signaled EMTs  for assistance. PHN arrived shortly after. Client alert and oriented x4, sitting upright in chair. Client stated felt nausea, chest tightness, headache to occipital area, and sharp pains to abdominal area as she was walking form vaccination room to observation. Client declined chest pain, shortness of breath, headache or blurry vision at this time. Vitals at 1520: blood pressure 127/70, pulse 70, oxygen 100%. Per client had already waited 30 mins in observation. Medical history of asthma years ago, gallbladder stones, gastritis. Current medication Omeprazole. Per client had dental surgery 1 month ago and has jaw pain, feels infection returning and has not followed up with dentist. PHN  asked client to stay longer in observation, client declined as had already waited 30 mins. Last set of vitals at 1527: blood pressure 111/58, pulse 66, oxygen 98%. PHN advised client to follow up with primary provider and dentist provider. ER precautions also given. Client accompanied by 2 people, client stated she would not drive. Client left facility with steady gait at 1530.
Fever; Arm pain; Tired; tingling sensation to finger tip of right hand; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), PAIN IN EXTREMITY (Arm pain), FATIGUE (Tired) and PARAESTHESIA (tingling sensation to finger tip of right hand) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), ARMODAFINIL (NUVIGIL) and DESOGESTREL, ETHINYLESTRADIOL (VIORELE) for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), PAIN IN EXTREMITY (Arm pain), FATIGUE (Tired) and PARAESTHESIA (tingling sensation to finger tip of right hand). At the time of the report, PYREXIA (Fever), PAIN IN EXTREMITY (Arm pain), FATIGUE (Tired) and PARAESTHESIA (tingling sensation to finger tip of right hand) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
First noticed hair started to fall out, after morning shower. By the end of Jan, I am bald!!!!  Being treated for alopecia areata at this time.  I have never had a flu shot before this time.
local redness, swelling, itching, discomfort at injection site (L deltoid region), onset 4 days after vaccination.
Substernal chest pain 2 days after receipt of primary SPV; Initially intermittent, then became constant; non-radiating; no other associated symptoms
swelling; irritating; redness; fever; Diverticulitis attack; Diarrhea; Pain in lower abdomen on both sides; This spontaneous case was reported by a consumer and describes the occurrence of DIVERTICULITIS (Diverticulitis attack) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced DIVERTICULITIS (Diverticulitis attack) (seriousness criterion medically significant), DIARRHOEA (Diarrhea) and ABDOMINAL PAIN LOWER (Pain in lower abdomen on both sides). On an unknown date, the patient experienced SWELLING (swelling), VACCINATION SITE IRRITATION (irritating), ERYTHEMA (redness) and PYREXIA (fever). At the time of the report, DIVERTICULITIS (Diverticulitis attack), SWELLING (swelling), VACCINATION SITE IRRITATION (irritating), ERYTHEMA (redness), DIARRHOEA (Diarrhea), ABDOMINAL PAIN LOWER (Pain in lower abdomen on both sides) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was tested via CT scan and diagnosis of diverticulitis was made.  As treatment, the patient was put on antibiotics by her doctor and she was expected to have more tests done as well.  No concomitant medications were reported.  Company comment:  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: significant follow: Additional events, treatment, Vaccine start date, lot number added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
3:45PM in the County Department of Public Health hallway, child experienced syncope related to administered vaccines: TDAP, MCV4, HPV#1.
pt recvd vax 27FEB96 & began to have rash on 2MAR96;faded in 2-3 days;10MAR96 another rash appeared over entire body;no fever, no photophobia;watery eyes;went to MD 11MAR96;MD stated pt had measles;no lab test done for dx;
Day after the vaccination I had chills and was very lethargic. Persisted till next morning. On Thurs 18th my left arm was red from my left elbow almost to the top of the arm. Problem Still persists. Using cold compresses.
Patient states she had a red, itch rash at the injection site for 7-10 days.
redness & swelling & pain from mid upper rt arm up & onto rt neck/inj into rt deltoid DPH resolved in 6-7 days;
Shot given at 12:00 noon. Witness to the event states pt started to have eyes roll back in his head and have a seizure around 3pm. Called ambulance and is in route to ER with active seizure. Pt was driving when he started to have symptoms and pulled off on the side of the road.
pt clearly tired yet was inconsolable;shortly thereafter had pain & cramps in abd;was irritable, clearly agitated & suffered from insomnia;cont for 12hr straight;abd pain & cramps cont & is believed to contributed to colic;
Baby born 3 days after mom's 3rd series for rabies vaccine post exposure series. Baby stiff all over.
Called patient per her request after she had come in and spoke with the pharmacist on duty regarding bumps around & on her scalp. She told me that she had bumps to breakout around her hairline and blisters to form on her scalp a few days after she received a shingles vaccine. She thought she was having an outbreak from shingles because of the vaccine. She said the other pharmacist had told her that the bumps were more than likely from the weave and not shingles. Patient had new placed braided extensions done to her hair the day that the vaccine was administered. I also advised her that the bumps around her hairline were most likely from the braids being too tight.
swollen super clavicular lymph node. heavy period 2 weeks after vaccination and longer period duration
I found out that I was pregnant four weeks after the second dose. I started to itch all over my body four weeks after the shot. I did not have a visible rash, but my dermatologist said it was a histamine reaction. I was intensely itchy for three days and then it went away  after five days. I had a miscarriage five weeks after the second dose which was a week after the itch started. I saw my OBGYN, PCP ER , Gastroenterologist and Dermatologist.  Due Date: 12/11/2021 Pregnancy Third Pregnancy
- Vaccine administration error,  - No adverse effects noted by RN and declined by parent (mother).   - vaccine administered by RN.  - Provider & Guardian notified. - Parent declines additional dose at this time  - Addressed error with staff and steps implemented to ensure this error does not occur again.
This spontaneous report was received from a nurse and refers to unspecified patients of unknown ages and genders. The patients' medical history, concurrent conditions and allergies were not reported. On unspecified dates since 14-DEC-2015, the unspecified patients were vaccinated with doses of PROQUAD (Merck) lot # L034930, expiration date: 03-MAR-2017, (strength, dose, frequency, route and anatomical location were not reported), which were exposed to temperatures outside the recommended range (incorrect product storage). Other suspect and concomitant therapies were not reported. No adverse events were reported, and no product quality complaint was involved. This is one of two reports received from the same reporter. Additional information has been requested.
Night/morning 1 - muscle aches nausea subsiding and and resolving in swollen mouth, throat, lips, glands, loss of voice (went to urgent care, place on antihistamines) Night/morning 2 - swollen eyes, lips, face, hands, feet Night/morning 3 - swollen hands/feet, abdominal itching Night/morning 4 - abdominal/leg itching, rash on arms and hand, loss of voice (went to ER, placed on steroid and different antihistamines) Night/morning 5 - lesser amount of abdominal/leg itching, rash on arms and hand Morning 6 - swelling of throat mid morning resolved with OTC medication Residual loss of voice/cottony mouth feeling, afternoon headaches
Suspected vaccination failure; shingles / getting over them now after about three weeks; pain wasn't as intense; itching has been horrible; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and pruritus. On an unknown date, the outcome of the vaccination failure, pain and pruritus were unknown and the outcome of the shingles was recovering/resolving.   It was unknown if the reporter considered the vaccination failure, shingles, pain and pruritus to be related to Shingles vaccine.  Additional details were provided as follows: Age at vaccination was not reported. The age group was selected as adult as per vaccine indication. The patient had the vaccination and still got the shingles again. The patient was getting over them after about three weeks. It was reported that the pain was not as intense but the itching had been horrible. The case was considered as suspected vaccination failure since the details regarding dose number, time to onset and laboratory confirmation were not provided.
2 minutes after injection slight burning at injection site which stopped 10 minutes later.  Next morning fever, fatigue, deep muscle pain across back of shoulders concentrated at base of neck, headache, ringing in ears.  Later that night, severe sudden muscle spasms on left side of lower back....spun me around and doubled me over...left me feeling a little breathless.  Next morning (day 3), still some deep muscle pain now dispersed across back,. Less burning at injection site, fever but less, coughing up some clear glen from lungs....breathing ok though, still fatigued.
Boost was administered prior to the recommended date of today 18-12-2021. It corresponded to him in the month of March 2022. Since the 6 months have not elapsed from the second dose to the third.
Headache, body ache, redness at the vaccine site, fever, nausea, dizziness, arm pain and stiffness, tiredness, chills, joint pain.
Patient is describing a change in hair texture and volume that when counting backwards to about the time she feels like it was happening she thinks is about the same time as the vaccine was given.
Chills and fever at 12hrs Fatigue for next 3 days Pain in lungs and sides for next 6 weeks
This spontaneous report as received from a nurse refers to a 14 years old patient (unknown gender). No concurrent condition, medical history or allergy/drug reactions were reported. On 27-MAY-2015, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) GARDASIL injection, dose number 3, lot # K006960, exp. date: 19-FEB-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
fever of 102 w/in 6hrs, also h/a lasting 2 days;
Break through covid infection, positive test 07Jan2022; Break through covid infection, positive test 07Jan2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Feb2021 (Lot number: EL3247) at the age of 44 years as dose 2, single and administered in arm left, administration date 26Jan2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), outcome "unknown", COVID-19 (medically significant) with onset 07Jan2022, outcome "unknown" and all described as "Break through covid infection, positive test 07Jan2022". The patient underwent the following laboratory tests and procedures: sars-cov-2 antibody test: (07Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of covid-19.  Clinical course: Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had been tested for COVID-19.
A report was received from a health care professional on 22OCT2003 concerning a 3 year old male vaccinee who received Fluvirin on 22OCT2003. On 22OCT2003 the three year old vaccinee received Fluvirin. The vaccinee had not experienced any adverse symptoms at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update report: 1DEC2003. Follow up information received from a health care professional indicated that the vaccinee received Fluvirin on 21OCT2003 and not on 22OCT2003 as was previously stated. No follow up pending,all information received.
Ringing in the ears after 2nd Shot; Metal taste in the mouth after 2nd Shot; Tender glands under chin & neck after 2nd Shot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TINNITUS (Ringing in the ears after 2nd Shot), DYSGEUSIA (Metal taste in the mouth after 2nd Shot) and TENDERNESS (Tender glands under chin & neck after 2nd Shot) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019F21A and 050E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Oct-2021, the patient experienced TINNITUS (Ringing in the ears after 2nd Shot), DYSGEUSIA (Metal taste in the mouth after 2nd Shot) and TENDERNESS (Tender glands under chin & neck after 2nd Shot). At the time of the report, TINNITUS (Ringing in the ears after 2nd Shot), DYSGEUSIA (Metal taste in the mouth after 2nd Shot) and TENDERNESS (Tender glands under chin & neck after 2nd Shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported. No treatment medications were reported.   This case was linked to MOD-2021-346379 (Patient Link).
Vaccine clinic RN went to inpatient ward with vaccine and questionnaire and appropriately screened and administered vaccine according to policy.  Patient was A&O x4 and also stated that she was in need of her second dose and consented to receive dose prior to going to rehab.   Vaccine clinic was informed on 5/13 that the patient?s husband had called and informed hospital that patient had received 2 COVID Pfizer doses already and the one she received as an outpatient on 5/12 was actually her 3rd vaccine.  This information was verified according to hospital EMAR there was a vaccine given on 3/26 and 4/16 for her first and second doses.   As of 3/26, the time of the administration of the first dose, the vaccine clinic was using the website VAMS in order to document vaccines administered in the clinic for reporting purposes.  Prior to the second dose, webiste VINI was implemented to replace VAMS and the second vaccine was recorded in VINI as per the new protocol for reporting.  When referencing VINI it appeared that only one vaccine dose had been administered, but it was the second and the first was recorded in the retired system VAMS.
On 03/26/2021 Ambulance Service recieved 90 vials of Moderna Covid-19 Vaccine  for the intent of vaccinating employees. Vaccine was kept in frozen storage within proper temperature requirements (-58°F and 5°F). On 05/02/2021 vaccine supply was transferred from freezer stroage to refridgeration storage in preperation for administration. On 05/13/2021 representatives from Ambulance Service went to facility and vaccinated twenty (20) employees, including this patient. All handling and mobile storage procedures were followed including the use of mobile refridgeration unit equipped with active temperature monitoring system. Patient was vaccinated without incident and no side effects were observed or reported. After vaccination was complete, a member of Ambulance Service was entering in patient information into Immunization Information System when it was discovered that the Moderna vaccine used had expired on 05/11/2021. Medical director was immediately contacted for further guidance.
On 3/29, date of first Moderna, doctor noticed necrobiosis lipoidica on right leg.  By 5/10 I was back at the doctor for swelling of legs. Started Keflex.  By 5/28-30 I was noticing that my forearms were swollen & hard, in addition to my ankles and lower legs.
Approximately 12 hrs after the vaccine, I was unable to get & maintain an erection which had never been a problem anytime prior, even in the preceding week.  I still continue to experience the same issue even today ( has been 20 days since vaccination. I continue to focus on healthy lifestyle & sleep routine.
devel diffuse itchy rash, presented to clinic on 14JUl93 w/extensive desquamatic of hand & feet;
Beginning the next day, severe muscle and joint aches with sore throat and headache, light sensitivity, extreme fatigue
This spontaneous report was received from a healthcare worker referring to unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date the patient was vaccinated with PROQUAD (dose and route were not reported), lot # M044719 and expiry date: 07-MAY-2018 for prophylaxis. The vaccine was exposed to temperature of 15 to 46 Fahrenheit for 75 minutes. There was a previous temperature excursion of 47 to 77 Fahrenheit for 10.5 hours. No adverse effects and no product quality complaint (PQC) was reported. No further information provided. This is one of the several reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1707USA007237: US-009507513-1707USA006714: US-009507513-1707USA007239.
Fever, stiff neck, pain in spine (felt like swelling), migraine, nausea, aches pain.
The patient was immunized against measles, mumps and rubella as a child, and received the MMR II in both 2014 (exact date unknown) and 11DEC2019, and has documented evidence of vaccine administration for both doses.; This spontaneous report was received from a pharmacist, referring to a 40-year-old patient of unknown gender. The patient's pertinent medical history, current conditions, previous drug reactions or allergies and concomitant medications were not reported.   The patient stated that, when he/she was a child was immunized (prophylaxis) against measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (formulation, strength, dose, vaccination scheme, route of administration, anatomical site of vaccination, lot number and expiration date were not reported), in 2014 the patient received another dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), prophylaxis (formulation, strength, dose, vaccination scheme, route of administration, anatomical site of vaccination, lot number and expiration date were not reported), on 11-DEC-2020 the patient received another dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), as prophylaxis (formulation, strength, dose, vaccination scheme, route of administration, anatomical site of vaccination, lot number R022423, which has been verified to be valid, expiration date reported and validated as 06-AUG-2020) (extra dose administered), the patient has documented evidence of vaccine administration for both doses.
Within hours of a hepatitis b vaccine I experienced massive pain to my feet, ankles, knees, hips, left elbow, right thumb. Not as severe but pains in my right upper chest and back. My left side started to recover in late January 2023 but I experienced a tingling  in nerves from my back to my foot. The right didn't start to recover until May 2023. I still have tingling on both sides but the left is on the back of my ankle to the foot and the right side tingles from my lower back to the foot. I believe that as my body adjusted to the traumas it received it caused 4 discs to bulge. I have been going to physical therapy. I was was prescribed two prescriptions of methylprednisolone 4mg and  two prescriptions of cyclobenzaprine 5mg. I had an MRI done and the results are attached.
Numb arm, bright red hands and face, teeth chattering for 12 hours, disoriented, fainting, lack of bladder control.
p/vax pt c/o flu like symptoms; T100; sweats; itching joints; fatigue;
Arm started to get itchy, was red and felt swollen, felt very hard to the touch. Probably the size of a baseball in terms of surface area.  Lasted about four days. Today it seems to be gone. No redness, swelling or itching.
Arm has redness at site of injection. 3 days later the site is still red and the redness has wrapped around her arm as well. no swelling but arm is warm.
Received rabies vaccine 6/10 and 6/17/14. Developed joint pain approx 6/19/14 and rash approx 6/21/14. Symptoms now resolved.